UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
SCHEDULE
13G
Under
the Securities Exchange Act of 1934
(Amendment
No. )*
Cidara
Therapeutics, Inc.
(Name
of Issuer)
Common
Stock, $0.0001 par value
(Title
of Class of Securities)
171757206
(CUSIP
Number)
November
26, 2024
(Date
of Event which Requires Filing of this Statement)
Check
the appropriate box to designate the rule pursuant to which this Schedule is filed:
| * | The
remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject
class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover
page. |
The
information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18
of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall
be subject to all other provisions of the Act (however, see the Notes).
1. |
NAMES
OF REPORTING PERSONS
Vivo
Opportunity Fund Holdings, L.P. |
2. |
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)
☐
(b)
þ |
3. |
SEC
USE ONLY
|
4. |
CITIZENSHIP
OR PLACE OF ORGANIZATION
Delaware |
NUMBER
OF
SHARES
BENEFICIALLY
OWNED
BY
EACH
REPORTING
PERSON
WITH |
5. |
SOLE
VOTING POWER
600,157
(1) |
6. |
SHARED
VOTING POWER
0 |
7. |
SOLE
DISPOSITIVE POWER
600,157
(1) |
8. |
SHARED
DISPOSITIVE POWER
0 |
9. |
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
600,157
(1) |
10. |
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ☐
|
11. |
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW 9
5.5%
(2) |
12. |
TYPE
OF REPORTING PERSON
PN |
| (1) | The
number represents shares of common stock, $0.0001 par value (the “Common Stock”) of Cidara Therapeutics, Inc. (the “Issuer”)
held of record by Vivo Opportunity Fund Holdings, L.P. Vivo Opportunity, LLC is the general partner of Vivo Opportunity Fund Holdings,
L.P. |
| (2) | Based
on 10,938,907 shares of Common Stock, which is the sum of (i) 7,046,633 shares of Common Stock outstanding as of November 4, 2024, as
reported by the Issuer in its Quarterly Report on Form 10-Q for the quarter ended September 30, 2024, filed with the Securities and Exchange
Commission (the “SEC”) on November 7, 2024, plus (ii) 3,892,274 shares of Common Stock issued at the closing of a private
placement offering, as reported by the Issuer in its Current Report on Form 8-K filed with the SEC on November 26, 2024. |
1. |
NAMES
OF REPORTING PERSONS
Vivo
Opportunity, LLC |
2. |
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)
☐
(b)
þ |
3. |
SEC
USE ONLY
|
4. |
CITIZENSHIP
OR PLACE OF ORGANIZATION
Delaware |
NUMBER
OF
SHARES
BENEFICIALLY
OWNED
BY
EACH
REPORTING
PERSON
WITH |
5. |
SOLE
VOTING POWER
600,157
(1) |
6. |
SHARED
VOTING POWER
0 |
7. |
SOLE
DISPOSITIVE POWER
600,157
(1) |
8. |
SHARED
DISPOSITIVE POWER
0 |
9. |
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
600,157
(1) |
10. |
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ☐
|
11. |
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW 9
5.5%
(2) |
12. |
TYPE
OF REPORTING PERSON
OO |
| (1) | The
number represents shares of Common Stock of the Issuer held of record by Vivo Opportunity Fund Holdings, L.P. Vivo Opportunity, LLC is
the general partner of Vivo Opportunity Fund Holdings, L.P. |
| (2) | Based
on 10,938,907 shares of Common Stock, which is the sum of (i) 7,046,633 shares of Common Stock outstanding as of November 4, 2024, as
reported by the Issuer in its Quarterly Report on Form 10-Q for the quarter ended September 30, 2024, filed with the SEC on November
7, 2024, plus (ii) 3,892,274 shares of Common Stock issued at the closing of a private placement offering, as reported by the Issuer
in its Current Report on Form 8-K filed with the SEC on November 26, 2024. |
1 |
NAMES
OF REPORTING PERSONS
Vivo Asia Opportunity Fund Holdings, L.P. |
2 |
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)
☐
(b)
þ |
3 |
SEC
USE ONLY
|
4 |
CITIZENSHIP
OR PLACE OF ORGANIZATION
Cayman Islands |
NUMBER
OF
SHARES
BENEFICIALLY
OWNED
BY
EACH
REPORTING
PERSON
|
5 |
SOLE
VOTING POWER
70,443
(1) |
6 |
SHARED
VOTING POWER
0 |
7 |
SOLE
DISPOSITIVE POWER
70,443 (1) |
8 |
SHARED
DISPOSITIVE POWER
0 |
9 |
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
70,443
(1) |
10 |
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ☐
|
11 |
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW 9
0.6% (2) |
12 |
TYPE
OF REPORTING PERSON
PN |
| (1) | The
number represents shares of Common Stock of the Issuer held of record by Vivo Asia Opportunity Fund Holdings, L.P. Vivo Opportunity
Cayman, LLC is the general partner of Vivo Asia Opportunity Fund Holdings, L.P. |
| (2) | Based on 10,938,907 shares of
Common Stock, which is the sum of (i) 7,046,633 shares of Common Stock outstanding as of November 4, 2024, 3 as reported by the
Issuer in its Quarterly Report on Form 10-Q for the quarter ended September 30, 2024, filed with the SEC on November 7, 2024, plus
(ii) 3,892,274 shares of Common Stock issued at the closing of a private placement offering, as reported by the Issuer in its
Current Report on Form 8-K filed with the SEC on November 26, 2024. |
1 |
NAMES
OF REPORTING PERSONS
Vivo Opportunity Cayman, LLC |
2 |
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)
☐
(b)
þ |
3 |
SEC
USE ONLY
|
4 |
CITIZENSHIP
OR PLACE OF ORGANIZATION
Cayman Islands |
NUMBER
OF
SHARES
BENEFICIALLY
OWNED
BY
EACH
REPORTING
PERSON
|
5 |
SOLE
VOTING POWER
70,443
(1) |
6 |
SHARED
VOTING POWER
0 |
7 |
SOLE
DISPOSITIVE POWER
70,443 (1) |
8 |
SHARED
DISPOSITIVE POWER
0 |
9 |
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
70,443
(1) |
10 |
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ☐
|
11 |
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW 9
0.6% (2) |
12 |
TYPE
OF REPORTING PERSON
OO |
| (1) | The
number represents shares of Common Stock of the Issuer held of record by Vivo Asia Opportunity Fund Holdings, L.P. Vivo Opportunity
Cayman, LLC is the general partner of Vivo Asia Opportunity Fund Holdings, L.P. |
| (2) | Based
on 10,938,907 shares of Common Stock, which is the sum of (i) 7,046,633 shares of Common Stock outstanding as of November 4, 2024, as
reported by the Issuer in its Quarterly Report on Form 10-Q for the quarter ended September 30, 2024, filed with the SEC on November
7, 2024, plus (ii) 3,892,274 shares of Common Stock issued at the closing of a private placement offering, as reported by the Issuer
in its Current Report on Form 8-K filed with the SEC on November 26, 2024. |
Item
1. (a) |
Name
of Issuer: |
Cidara
Therapeutics, Inc. (the “Issuer”)
|
(b) |
Address
of Issuer’s Principal Executive Offices: |
6310
Nancy Ridge Drive, Suite 101
San
Diego, CA 92121
Item
2. (a) |
Name
of Person Filing: |
Vivo
Opportunity Fund Holdings, L.P. and its General Partner Vivo Opportunity, LLC
Vivo
Asia Opportunity Fund Holdings, L.P and its General Partner Vivo Opportunity Cayman, LLC
|
(b) |
Address
of Principal Business Office or, if None, Residence: |
192
Lytton Avenue, Palo Alto, CA 94301
Vivo
Opportunity Fund Holdings, L.P. is a Delaware limited partnership.
Vivo
Opportunity, LLC is a Delaware limited liability company.
Vivo
Asia Opportunity Fund Holdings, L.P. is a Cayman Islands limited partnership.
Vivo
Opportunity Cayman, LLC is a Cayman Islands limited liability company.
|
(d) |
Title
of Class of Securities: |
Common
Stock, $0.0001 par value
171757206
Item
3. |
If
This Statement is Filed Pursuant to §§
240.13d-1(b), or 240.13d-2(b) or (c),
Check Whether the Person Filing is a: |
|
(a) |
☐ |
Broker
or dealer registered under Section 15 of the Act. |
|
|
|
|
|
(b) |
☐ |
Bank
as defined in Section 3(a)(6) of the Act. |
|
|
|
|
|
(c) |
☐ |
Insurance
company as defined in Section 3(a)(19) of the Act. |
|
|
|
|
|
(d) |
☐ |
Investment
company registered under Section 8 of the Investment Company Act of 1940. |
|
|
|
|
|
(e) |
☐ |
An
investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E); |
|
|
|
|
|
(f) |
☐ |
An
employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F); |
|
|
|
|
|
(g) |
☐ |
A
parent holding company or control person in accordance with § 240.13d-1(b)(l)(ii)(G); |
|
(h) |
☐ |
A
savings association as defined in Section 3(b) of the Federal Deposit Insurance Act; |
|
|
|
|
|
(i) |
☐ |
A
church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act; |
|
|
|
|
|
(j) |
☐ |
A
non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J); |
|
|
|
|
|
(k) |
☐ |
Group,
in accordance with § 240.13d-1(b)(l)(ii)(K). |
If
filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1(ii)(j), please
specify the type of institution: ________________
Not
Applicable.
|
(a) |
Amount
Beneficially Owned: |
Vivo
Opportunity, LLC beneficially owns 600,157 shares of Common Stock. The securities are held of record by Vivo Opportunity Fund Holdings,
L.P. Vivo Opportunity, LLC is the general partner of Vivo Opportunity Fund Holdings, L.P.
Vivo
Opportunity Cayman, LLC beneficially owns 70,443 shares of Common Stock. The securities are held of record by Vivo Asia Opportunity Fund
Holdings, L.P. Vivo Opportunity Cayman, LLC is the general partner of Vivo Asia Opportunity Fund Holdings, L.P.
Vivo
Opportunity Fund Holdings, L.P.: 5.5%
Vivo
Opportunity, LLC: 5.5%
Vivo
Asia Opportunity Fund Holdings, L.P.: 0.6%
Vivo
Opportunity Cayman, LLC.: 0.6%
|
(c) |
Number
of shares as to which such person has: |
|
(i) |
Sole
power to vote or to direct the vote:
Vivo
Opportunity Fund Holdings, L.P.: 600,157 shares
Vivo
Opportunity, LLC: 600,157 shares |
Vivo
Asia Opportunity Fund Holdings, L.P.: 70,443 shares
Vivo
Opportunity Cayman, LLC: 70,443 shares
|
(ii) |
Shared
power to vote or to direct the vote: 0 |
|
(iii) |
Sole
power to dispose or to direct the disposition of:
Vivo
Opportunity Fund Holdings, L.P.: 600,157 shares
Vivo
Opportunity, LLC: 600,157 shares
Vivo
Asia Opportunity Fund Holdings, L.P.: 70,443 shares
Vivo
Opportunity Cayman, LLC: 70,443 shares |
|
(iv) |
Shared
power to dispose of or to direct the disposition of: 0 |
Item
5. |
Ownership
of Five Percent or Less of a Class. |
Not
applicable.
Item
6. |
Ownership
of More than Five Percent on Behalf of Another Person. |
Not
Applicable.
Item
7. |
Identification
and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. |
Not
Applicable.
Item
8. |
Identification
and Classification of Members of the Group. |
Not
applicable.
Item
9. |
Notice
of Dissolution of Group. |
Not
applicable.
By
signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not
held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired
and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely
in connection with a nomination under §240.14a11.
SIGNATURE
After
reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete
and correct.
Date:
December 9, 2024
Vivo
Opportunity Fund Holdings, L.P.
By:
Vivo Opportunity, LLC, its General Partner
/s/
Kevin Dai |
|
Name:
Kevin Dai |
|
Title:
Managing Member |
|
Vivo
Opportunity, LLC
/s/
Kevin Dai |
|
Name:
Kevin Dai |
|
Title:
Managing Member |
|
Vivo
Asia Opportunity Fund Holdings, L.P.
By:
Vivo Opportunity Cayman, LLC, its General Partner
/s/
Kevin Dai |
|
Name:
Kevin Dai |
|
Title:
Managing Member |
|
Vivo
Opportunity Cayman, LLC
/s/
Kevin Dai |
|
Name:
Kevin Dai |
|
Title:
Managing Member |
|
EXHIBIT
INDEX
EXHIBIT
99.1
Joint
Filing Agreement
The
undersigned acknowledge and agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned and that
all subsequent amendments to this statement on Schedule 13G shall be filed on behalf of each of the undersigned without the necessity
of filing additional joint filing statements. The undersigned acknowledge that each shall be responsible for the timely filing of such
amendments, and for the completeness and accuracy of the information concerning him, her or it contained herein, but shall not be responsible
for the completeness and accuracy of the information concerning the other entities or persons, except to the extent that he, she or it
knows or has reason to believe that such information is inaccurate.
Date:
December 9, 2024
Vivo Opportunity Fund Holdings, L.P.
|
|
|
|
|
By: |
Vivo Opportunity, LLC, its General Partner |
|
|
|
|
/s/
Kevin Dai |
|
Name: |
Kevin Dai |
|
Title: |
Managing Member |
|
|
|
|
Vivo Opportunity, LLC |
|
|
|
|
/s/
Kevin Dai |
|
Name: |
Kevin Dai |
|
Title: |
Managing Member |
|
|
|
|
Vivo Asia Opportunity Fund Holdings,
L.P. |
|
|
|
|
By: |
Vivo Opportunity Cayman, LLC, its General Partner |
|
|
|
|
/s/
Kevin Dai |
|
Name: |
Kevin Dai |
|
Title: |
Managing Member |
|
|
|
|
Vivo Opportunity Cayman, LLC |
|
|
|
|
/s/
Kevin Dai |
|
Name: |
Kevin Dai |
|
Title: |
Managing Member |
|
Cidara Therapeutics (NASDAQ:CDTX)
Historical Stock Chart
From Dec 2024 to Jan 2025
Cidara Therapeutics (NASDAQ:CDTX)
Historical Stock Chart
From Jan 2024 to Jan 2025